Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Units: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1,133,722,333,79,
%Companies according to biotechnology used: Genetic code,33,40,19,32,
%Companies according to biotechnology used: Functional units,41,45,38,23,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,24,28,15,26,
%Companies according to biotechnology used: Bioprocesses,50,39,76,35,
%Companies according to biotechnology used: Sub-cellular organisms,6,8,2,0,
%Companies according to biotechnology used: Bio-computing,24,33,9,11,
%Companies according to biotechnology used: Nanobiotechnology,13,16,8,4,
%Companies according to biotechnology used: Other,14,16,8,30,
Companies in which biotechnology activities are: Main and/or exclusive,603,490,99,15,
Companies in which biotechnology activities are: A secondary line of business,173,97,60,16,
Companies in which biotechnology activities are: A tool necessary for production,357,135,175,48,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,59,24,6,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,18,20,11,27,
%Company by field(s) of ultimate application of biotechnology use: Food products,31,23,51,23,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,20,18,62,
%Company by field(s) of ultimate application of biotechnology use: Environment,14,13,15,14,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,14,12,1,
Personnel in R&D in biotechnology (no. of persons),11,510,7,769,3,054,687,
Personnel in R&D in biotechnology (no. of persons): Researchers,6,202,4,554,1,408,241,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,5,308,3,215,1,646,446,
Personnel in R&D in biotechnology (no. of persons): women,6,389,4,518,1,543,328,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3,304,2,434,754,115,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3,086,2,084,789,213,
Personnel in R&D in biotechnology (FTE),8,236.9,5,941.7,1,868.5,426.7,
Personnel in R&D in biotechnology (FTE): Researchers,4,596.1,3,468.7,963.3,164.1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3,640.8,2,473.0,905.3,262.6,
Personnel in R&D in biotechnology (FTE): women,4,698.5,3,453.0,1,020.7,224.9,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2,512.5,1,878.4,557.4,76.6,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2,186.0,1,574.5,463.3,148.2,
Internal expenditure on R&D (thousands of euros),769,431,533,657,201,922,33,852,
1) By nature of the expense: Current expenses,719,715,504,270,185,577,29,868,
1.1) Remuneration to researchers,221,447,149,223,64,648,7,576,
1.2) Remuneration to technicians and assistants,122,809,75,033,41,097,6,679,
1.3) Other current expenses,375,459,280,014,79,832,15,614,
2) By nature of the expense: Capital expenses,49,715,29,387,16,345,3,984,
2.1) Land and buildings,9,521,3,329,4,506,1,687,
2.2) Equipment and instruments,30,466,18,712,9,484,2,269,
2.3) Acquisition of specific R&D software,1,810,1,279,508,23,
2.4) Otros productos de propiedad intelectual específicos para I+D,7,919,6,066,1,847,5,
1.1) By origin of the funds: Own funds,490,913,304,305,156,340,30,268,
1.2) By origin of the funds: From companies,82,548,76,853,5,695,0,
1.3) By origin of the funds: Public Administration funds,96,809,83,993,11,520,1,296,
1.4) By origin of the funds: From Universities,197,185,12,0,
1.5) By origin of the funds: From non profit private institutions,4,766,4,766,0,0,
1.6) By origin of the funds: Foreign funds,94,197,63,555,28,355,2,288,
Purchase of R&D services in biotechnology (thousands of euros),120,281,60,387,59,506,389,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,69,564,15,873,53,360,331,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,50,718,44,514,6,146,58,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,45,54,27,41,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,11,16,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,16,16,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,15,12,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,16,19,11,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,18,21,13,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,15,16,13,20,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,38,33,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,52,56,42,57,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,21,15,29,
% Companies that have requested biotechnology patents in Biotechnology,15,17,11,6,
Number of patents requested,681,493,154,34,
% Companies with income of an international origin related to biotechnological activities,24.3,29.0,18.4,6.4,
% Turnover representing income of an international origin related to biotechnological activities,1.00,4.00,1.00,0.00,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,59.60,46.80,62.90,94.50,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,40.40,53.20,37.10,5.50,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,80.40,69.20,83.40,99.30,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,16.50,17.00,16.40,0.00,
% Income of an international origin related with activities according to the classification: Operating source abroad,2.20,9.70,0.20,0.70,
% Income of an international origin related with activities according to the classification: Other,0.90,4.10,0.00,0.00,
Notes:
1) '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Source: National Statistics Institute